Glycemic control with Humalog® Mix25™ in type 2 diabetes inadequately controlled with glyburide

This publication has 15 references indexed in Scilit:

• Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
  BMJ, 2000
• Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia an underestimated evil?
  Experimental and Clinical Endocrinology & Diabetes, 2000
• The narrow therapeutic window of glycated hemoglobin and assay variability
  Metabolism, 1999
• Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program.
  Diabetes Care, 1999
• The Importance of Hyperglycemia in the Nonfasting State to the Development of Cardiovascular Disease
  Endocrine Reviews, 1998
• The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications
  Diabetic Medicine, 1998
• Nighttime Insulin Kinetics and Glycemic Control in Type 1 Diabetes Patients Following Administration of an Intermediate-Acting Lispro Preparation
  Diabetes Care, 1997
• Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization
  JAMA, 1997
• The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial
  Diabetes, 1995
• The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
  New England Journal of Medicine, 1993